Statins Market, By Product Type (Generic Drugs and Branded Drugs), By Drug Class (Atorvastatin, Fluvastatin, Lovastatin, Pravastatin, Rosuvastatin, Simvastatin, and Pitavastatin), By Indication Prevention of Myocardial (Infarction, Stroke Prevention, Type 2 Diabetes-related MI and Stroke Prevention, Coronary Heart Disease Risk Reduction, Primary Hyperlipidemia Treatment, Mixed Dyslipidemia Treatment, and Hypertriglyceridemia and Primary Dysbetalipoproteinemia, Homozygous Familial Hypercholesterolemia (HoFH) Treatment, and Heterozygous Familial Hypercholesterolemia (HeFH) Treatment (Pediatric)), By Type of Statin (Natural Statins and Synthetic Statins), By Formulation (Tablets and Capsules), By Strength (10 mg, 20 mg, 40 mg, and 80 mg), By Sales Channel (Prescription and Over-the-Counter), By Age Group (Pediatric, Adult, and Geriatric), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)